Article
A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during…
medRxiv · 2023 · Michael P. Plebanek
Key facts
| Title | A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression |
|---|---|
| First author | Michael P. Plebanek |
| Journal | medRxiv |
| Published | Apr 28, 2023 |
| DOI | 10.1101/2023.04.26.538456 |
| Devices mentioned | 006772, K030528, K031042, K031044, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183 and 5 more |
| Product codes mentioned | JCF, JJH, LXG, MVU, PFF, PFT, JIY, KNK, LCP |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1